Maria Laura Avignolo
07/12/2021 1:31 PM
Clarín.com
Society
Updated 07/12/2021 1:31 PM
Health Minister Carla Vizzotti and Presidential Advisor Cecilia Nicolini begin a high-level political and health visit in Britain today.
For the first time during Alberto Fernández's government, a minister from his cabinet will meet in London with
two senior British ministers
to discuss vaccination and with the vice president of AstraZeneca in Cambridge, to see if Argentina can
join the “full cycle of production. of the vaccine ”
and not having to depend on Mexico for the completion of the product, as before.
His project is to accelerate production and inoculation before
the advance of the Delta variant
and the proximity of the
legislative elections
.
They will also meet scientists from Oxford.
A big step within the Kirchner government and an
unusual advance in an
ideologically fragmented
bilateral relationship
.
Vizzotti will participate on Tuesday in a meeting with the minister for the deployment of Vaccines against Covid, Nadhim Zahawi, in a country that has vaccinated 45.6 million people with a single dose of AstraZeneca. He will also see the new and former health minister. Chancellor of Finance, former Pakistani-born banker Sajid Javid in London.
As the Delta variant advances, the British government is keen to
shorten the difference between one dose and another
to four weeks to inoculate the young.
So far they are the most resistant to vaccines, to the point that they put up tents at Wembley Stadium in the final of the European Cup to encourage them to be vaccinated and not miss the holidays.
One of the most important steps in the mission of the Argentine Minister of Health is her meeting with the executive vice president of AstraZeneca, Menelao Pangalos, with whom she will visit the R&D center and the company.
He will propose to him if they can consider Argentina joining the so-called “complete vaccine production cycle”, from which
the active substance
is already
produced
and officially bottled in Mexico.
Although the AstraZeneca vaccine that arrives in Argentina comes mainly from a North American plant, where the vaccine has not yet been authorized by the drug agency.
Within the framework of the agreement that the government signed with AstraZeneca for the acquisition of vaccines from that laboratory, work will be done to confirm in detail the “
delivery schedule
, monitor production and consider the possibility of Argentina joining the so-called cycle complete production of the vaccine, "according to an official statement from the Argentine Presidency.
In it, it is reported that the Argentine Ministry of Health has been carrying out, together with the technical teams of the United Kingdom's health portfolio, an
exchange
work
on vaccination strategies
and articulation around the policies against Covid that are carried out in both countries.
On the ministerial agenda, assisted by the ambassador in London, Javier Figueroa, the minister and the presidential advisor will meet with the special envoy on Antimicrobial Resistance Issues, Dame Sally Davies.
They will then meet with the British Chancellor's Minister for Europe and America, Wendy Morton, before meeting with AstraZeneca's Vice President in Cambridge.
They will visit the Wellcome Sanger Institute, an organization specializing in genetics and genome.
In Hixton, near Cambridge.
They will hold a meeting with scientists from that organization.
During the official tour they will meet with Oxford scientists to learn about the progress
of production strategies, new variants, reinforcements
, clinical trials in children, adolescents and girls.
The Delta variant is especially affecting young people and is the great new concern of all governments when preparing their strategies to combat it.
In Great Britain and France the variant is already the majority.
Paris. Correspondent
Look also
"Public Vaccination Monitor": 5 reasons why the name was great for the creation of Carla Vizzotti
Rabies alert: 9 people received treatment and pet vaccination continues to decline